Showing results (451-460 of 591) with videos related to
Sort By:
Pageof 60
British Journal of Clinical Pharmacology|March 22, 2001
Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patientsP Tanswell, P Garin-Chesa, W J Rettig, et al.Cancer Immunity|March 10, 2009
Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8Stefan Bauer, Nicole Adrian, Uta Siebenborn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancerAli O Gure, Ramon Chua, Barbara Williamson, et al.Cancer Immunity|January 30, 2010
Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patientsNikoletta Lendvai, Sacha Gnjatic, Erika Ritter, et al.Cancer Immunity|August 25, 2007
Expression of cancer-testis (CT) antigens in placentaAchim A Jungbluth, Wilson A Silva, Kristin Iversen, et al.Proceedings of the National Academy of Sciences of the United States of America|August 30, 2003
CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responsesHiroyoshi Nishikawa, Takuma Kato, Koji Tanida, et al.Biomed Research International|November 7, 2013
The human cell surfaceome of breast tumorsJúlia Pinheiro Chagas da Cunha, Pedro Alexandre Favoretto Galante, Jorge Estefano Santana de Souza, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTLJ L Chen, P R Dunbar, U Gileadi, et al.Proceedings of the National Academy of Sciences of the United States of America|March 15, 2001
Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigenT Ono, T Kurashige, N Harada, et al.British Journal of Cancer|August 1, 1996
Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM)P Antoniw, A P Farnsworth, A Turner, et al.Pageof 60